What are the major opportunities in the angiotensin receptor blockers (ARBs) market? What are the strategies for the angiotensin receptor blockers (ARBs) market?

For detailed insights on the major opportunities and strategies in the angiotensin receptor blockers (ARBs) market, Read More

How does the angiotensin receptor blockers (ARBs) market relate to the overall economy and other similar markets?

For detailed insights on angiotensin receptor blockers (ARBs) market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the angiotensin receptor blockers (ARBs) market growth? SWOT analysis of the angiotensin receptor blockers (ARBs) market.

For detailed insights on the key dynamics influencing the angiotensin receptor blockers (ARBs) market growth and SWOT analysis of the angiotensin receptor blockers (ARBs) industry, Read More

Angiotensin Receptor Blockers (ARBs) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Angiotensin Receptor Blockers (ARBs) Market Report 2026

Name: Angiotensin Receptor Blockers (ARBs) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan), By Application (Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Angiotensin Receptor Blockers (ARBs) Market Overview

• Angiotensin Receptor Blockers (ARBs) market size has reached to $8.78 billion in 2025

• Expected to grow to $11.02 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%

• Growth Driver: Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market

• Market Trend: Innovative Product Solution In The Angiotensin Receptor Blockers Market

• North America was the largest region in 2025.

What Is Covered Under Angiotensin Receptor Blockers (ARBs) Market?

Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder.

The main products of angiotensin receptor blockers (ARBs) include valsartan, losartan, irbesartan, azilsartan and olmesartan. Losartan is an angiotensin receptor blocker that lowers the risk of stroke while treating hypertension and diabetic nephropathy. Their various applications include hypertension, cardiovascular diseases, kidney diseases, and others for use by end-users such as hospitals, specialty clinics, and ambulatory surgical centers.

Angiotensin Receptor Blockers (ARBs) Market Global Report 2026 Market Report bar graph

What Is The Angiotensin Receptor Blockers (ARBs) Market Size and Share 2026?

The angiotensin receptor blockers (arbs) market size has grown steadily in recent years. It will grow from $8.78 billion in 2025 to $9.18 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to rising prevalence of hypertension, growing awareness of cardiovascular diseases, expansion of hospital networks, introduction of new arb molecules, increasing research in kidney disease treatments.

What Is The Angiotensin Receptor Blockers (ARBs) Market Growth Forecast?

The angiotensin receptor blockers (arbs) market size is expected to see steady growth in the next few years. It will grow to $11.02 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to aging population, growing demand for personalized medicine, technological advancements in drug delivery systems, increase in healthcare expenditure, expansion of specialty clinics. Major trends in the forecast period include personalized hypertension management, growth in chronic kidney disease treatments, expansion of cardiovascular disease therapies, increasing adoption of oral arb formulations, rise in hospital & specialty clinic prescriptions.

Book your 30 minutes free consultation with our research experts

Global Angiotensin Receptor Blockers (ARBs) Market Segmentation

1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

What Are The Drivers Of The Angiotensin Receptor Blockers (ARBs) Market?

The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. Angiotensin receptor blockers lower blood pressure and improve the heart's capacity to pump blood by helping in vein and artery relaxation, which can minimize the risk of cardiovascular disease. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the angiotensin receptor blockers market.

The increase in the prevalence of hypertension diseases is expected to propel the growth of the angiotensin receptor blockers (ARBs) market going forward. Hypertension, often known as high or rising blood pressure, is a disorder characterized by chronically elevated blood vessel pressure. Angiotensin receptor blockers (ARBs) are a type of medication that is commonly used to treat hypertension. They primarily function by relaxing and widening the blood arteries, giving the blood greater room to pass through. Thus, increasing hypertension diseases among people will increase the demand for angiotensin receptor blockers. For instance, in March 2023, the World Health Organization, a Switzerland-based intergovernmental organization, published that approximately 1.28 billion adults aged 30 to 79 globally have hypertension, with the majority (two-thirds) residing in low- and middle-income countries. It is estimated that 46% of adults with hypertension are unaware of their condition. Therefore, the increase in the prevalence of hypertension diseases is driving the growth of the angiotensin receptor blockers (ARBs) industry.

Key Players In The Global Angiotensin Receptor Blockers (ARBs) Market

Major companies operating in the angiotensin receptor blockers (arbs) market are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma, Thermo Fisher Scientific.

Global Angiotensin Receptor Blockers (ARBs) Market Trends and Insights

Major companies in the angiotensin receptor blocker market are developing advanced products, such as angiotensin receptor neprilysin inhibitors, to enhance treatment options and improve outcomes for patients with cardiovascular conditions. Angiotensin receptor neprilysin inhibitors (ARNIs) are a class of medications used to treat heart failure. For instance, in January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched sacubitril + valsartan tablets, which specialize in the treatment of heart failure, specifically targeting heart failure with reduced ejection fraction (HFrEF). This combination falls under the class of medications known as ARNI (angiotensin receptor neprilysin inhibitors). Sacubitril enhances the natriuretic peptide (NP) system, which alleviates fluid overload and promotes blood vessel dilation, while valsartan blocks the renin-angiotensin system (RAS) to lower blood pressure and lessens the heart's workload. Together, they effectively improve heart failure symptoms, reduce the risk of cardiovascular mortality, and decrease the chances of hospitalization due to heart failure. They are marketed under the brand name Sacu V.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angiotensin Receptor Blockers (ARBs) Market?

The angiotensin receptor blockers (ARBs) market consists of sales of candesartan and eprosartan. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Angiotensin Receptor Blockers (ARBs) Market Report 2026?

The angiotensin receptor blockers (arbs) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the angiotensin receptor blockers (arbs) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Angiotensin Receptor Blockers (ARBs) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$9.18 billion
Revenue Forecast In 2035	$11.02 billion
Growth Rate	CAGR of 4.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Comp
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Angiotensin Receptor Blockers (ARBs) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Angiotensin Receptor Blockers (ARBs) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Angiotensin Receptor Blockers (ARBs) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Personalized Hypertension Management

4.2.2 Growth In Chronic Kidney Disease Treatments

4.2.3 Expansion Of Cardiovascular Disease Therapies

4.2.4 Increasing Adoption Of Oral Arb Formulations

4.2.5 Rise In Hospital & Specialty Clinic Prescriptions

5. Angiotensin Receptor Blockers (ARBs) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Ambulatory Surgical Centers

5.4 Pharmacies

5.5 Home Healthcare Providers

6. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Angiotensin Receptor Blockers (ARBs) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Angiotensin Receptor Blockers (ARBs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Angiotensin Receptor Blockers (ARBs) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Angiotensin Receptor Blockers (ARBs) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Angiotensin Receptor Blockers (ARBs) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Angiotensin Receptor Blockers (ARBs) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Angiotensin Receptor Blockers (ARBs) Market Segmentation

9.1. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

9.2. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

9.3. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Ambulatory Surgical Centers

10. Angiotensin Receptor Blockers (ARBs) Market Regional And Country Analysis

10.1. Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market

11.1. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Angiotensin Receptor Blockers (ARBs) Market

12.1. China Angiotensin Receptor Blockers (ARBs) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Angiotensin Receptor Blockers (ARBs) Market

13.1. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Angiotensin Receptor Blockers (ARBs) Market

14.1. Japan Angiotensin Receptor Blockers (ARBs) Market Overview

14.2. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Angiotensin Receptor Blockers (ARBs) Market

15.1. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Angiotensin Receptor Blockers (ARBs) Market

16.1. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Angiotensin Receptor Blockers (ARBs) Market

17.1. South Korea Angiotensin Receptor Blockers (ARBs) Market Overview

17.2. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Angiotensin Receptor Blockers (ARBs) Market

18.1. Taiwan Angiotensin Receptor Blockers (ARBs) Market Overview

18.2. Taiwan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Angiotensin Receptor Blockers (ARBs) Market

19.1. South East Asia Angiotensin Receptor Blockers (ARBs) Market Overview

19.2. South East Asia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Angiotensin Receptor Blockers (ARBs) Market

20.1. Western Europe Angiotensin Receptor Blockers (ARBs) Market Overview

20.2. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Angiotensin Receptor Blockers (ARBs) Market

21.1. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Angiotensin Receptor Blockers (ARBs) Market

22.1. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Angiotensin Receptor Blockers (ARBs) Market

23.1. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Angiotensin Receptor Blockers (ARBs) Market

24.1. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Angiotensin Receptor Blockers (ARBs) Market

25.1. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market

26.1. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market Overview

26.2. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Angiotensin Receptor Blockers (ARBs) Market

27.1. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Angiotensin Receptor Blockers (ARBs) Market

28.1. North America Angiotensin Receptor Blockers (ARBs) Market Overview

28.2. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Angiotensin Receptor Blockers (ARBs) Market

29.1. USA Angiotensin Receptor Blockers (ARBs) Market Overview

29.2. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Angiotensin Receptor Blockers (ARBs) Market

30.1. Canada Angiotensin Receptor Blockers (ARBs) Market Overview

30.2. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Angiotensin Receptor Blockers (ARBs) Market

31.1. South America Angiotensin Receptor Blockers (ARBs) Market Overview

31.2. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Angiotensin Receptor Blockers (ARBs) Market

32.1. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Angiotensin Receptor Blockers (ARBs) Market

33.1. Middle East Angiotensin Receptor Blockers (ARBs) Market Overview

33.2. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Angiotensin Receptor Blockers (ARBs) Market

34.1. Africa Angiotensin Receptor Blockers (ARBs) Market Overview

34.2. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Angiotensin Receptor Blockers (ARBs) Market Regulatory and Investment Landscape

36. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Company Profiles

36.1. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Angiotensin Receptor Blockers (ARBs) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Angiotensin Receptor Blockers (ARBs) Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Angiotensin Receptor Blockers (ARBs) Market Other Major And Innovative Companies

GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila

38. Global Angiotensin Receptor Blockers (ARBs) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market

40. Angiotensin Receptor Blockers (ARBs) Market High Potential Countries, Segments and Strategies

40.1 Angiotensin Receptor Blockers (ARBs) Market In 2030 - Countries Offering Most New Opportunities

40.2 Angiotensin Receptor Blockers (ARBs) Market In 2030 - Segments Offering Most New Opportunities

40.3 Angiotensin Receptor Blockers (ARBs) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Angiotensin Receptor Blockers (ARBs) Market, Overview Of Key Products - Product Examples

Table 2: Global Angiotensin Receptor Blockers (ARBs) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Angiotensin Receptor Blockers (ARBs) Market, Supply Chain Analysis

Table 4: Global Angiotensin Receptor Blockers (ARBs) Market, Major Raw Material Providers

Table 5: Global Angiotensin Receptor Blockers (ARBs) Market, Major Resource Providers

Table 6: Global Angiotensin Receptor Blockers (ARBs) Market, Major Manufacturers (Suppliers)

Table 7: Global Angiotensin Receptor Blockers (ARBs) Market, Major Distributors And Channel Partners

Table 8: Global Angiotensin Receptor Blockers (ARBs) Market, Key Technologies & Future Trends

Table 9: Global Angiotensin Receptor Blockers (ARBs) Market, Major Trends

Table 10: Global Angiotensin Receptor Blockers (ARBs) Market, Major End Users

Table 11: Global Angiotensin Receptor Blockers (ARBs) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Angiotensin Receptor Blockers (ARBs) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Angiotensin Receptor Blockers (ARBs) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Angiotensin Receptor Blockers (ARBs) Market - TAM, US$ Billion, 2025

Table 15: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Taiwan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Taiwan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South East Asia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South East Asia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Global Angiotensin Receptor Blockers (ARBs) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 93: Global Angiotensin Receptor Blockers (ARBs) Market - Company Scoring Matrix

Table 94: Pfizer Inc. Financial Performance

Table 95: Novartis AG Financial Performance

Table 96: Merck & Co. Inc. Financial Performance

Table 97: AstraZeneca Plc. Financial Performance

Table 98: Bristol-Myers Squibb Company Financial Performance

Table 99: Global Angiotensin Receptor Blockers (ARBs) Market, Competitive Benchmarking (In USD Billions)

Table 100: Global Angiotensin Receptor Blockers (ARBs) Market, Competitive Dashboard

Table 101: Global Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 102: Global, Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 103: Global, Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 104: Global, Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Angiotensin Receptor Blockers (ARBs) Market, Overview Of Key Products - Product Examples

Figure 2: Global Angiotensin Receptor Blockers (ARBs) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Angiotensin Receptor Blockers (ARBs) Market, Supply Chain Analysis

Figure 4: Global Angiotensin Receptor Blockers (ARBs) Market, Major Raw Material Providers

Figure 5: Global Angiotensin Receptor Blockers (ARBs) Market, Major Resource Providers

Figure 6: Global Angiotensin Receptor Blockers (ARBs) Market, Major Manufacturers (Suppliers)

Figure 7: Global Angiotensin Receptor Blockers (ARBs) Market, Major Distributors And Channel Partners

Figure 8: Global Angiotensin Receptor Blockers (ARBs) Market, Key Technologies & Future Trends

Figure 9: Global Angiotensin Receptor Blockers (ARBs) Market, Major Trends

Figure 10: Global Angiotensin Receptor Blockers (ARBs) Market, Major End Users

Figure 11: Global Angiotensin Receptor Blockers (ARBs) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Angiotensin Receptor Blockers (ARBs) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Angiotensin Receptor Blockers (ARBs) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Angiotensin Receptor Blockers (ARBs) Market - TAM, US$ Billion, 2025

Figure 15: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Taiwan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Taiwan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South East Asia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South East Asia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Global Angiotensin Receptor Blockers (ARBs) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 93: Global Angiotensin Receptor Blockers (ARBs) Market - Company Scoring Matrix

Figure 94: Pfizer Inc. Financial Performance

Figure 95: Novartis AG Financial Performance

Figure 96: Merck & Co. Inc. Financial Performance

Figure 97: AstraZeneca Plc. Financial Performance

Figure 98: Bristol-Myers Squibb Company Financial Performance

Figure 99: Global Angiotensin Receptor Blockers (ARBs) Market, Competitive Benchmarking (In USD Billions)

Figure 100: Global Angiotensin Receptor Blockers (ARBs) Market, Competitive Dashboard

Figure 101: Global Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 102: Global, Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 103: Global, Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 104: Global, Angiotensin Receptor Blockers (ARBs) Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Disposable Cutlery Market Report 2026 - Global Outlook – By Type (Spoon, Fork, Knife), By Material (Plastic, Wood), By Sales Channel (Supermarkets, Hypermarkets, Convenience Stores, Specialty Stores, Discount Stores, E-R...

Osteoporosis Treatment Market Report 2026 - Global Outlook – By Drug Type (Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog)...

Air Coolers Market Report 2026 - Global Outlook – By Type (Tower, Desert, Other Types), By Size (Spot Cooler, Medium Space Cooler, Large Space Cooler), By Application (Industrial, Residential, Commercial) – Market Size, ...

Anti-Hypertensive Drugs Market Report 2026 - Global Outlook – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Chann...

French Fries Market Report 2026 - Global Outlook – By Product (Fresh, Frozen), By Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Online, Distributors, Direct Purchase), By End-Use (Food Service,...

Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Str...

Smart Ticketing Market Report 2026 - Global Outlook – By Product (Ticket Machine, E-Ticket, E-Kiosk, Request Tracker), By Component (Hardware, Software), By System (Open Payment System, Smart Card, Near-Field Communicati...

Frequently Asked Questions

How big is the Angiotensin Receptor Blockers (ARBs) Market?

The Angiotensin Receptor Blockers (ARBs) market was valued at $8.78 billion in 2025, increased to $9.18 billion in 2026, and is projected to reach $11.02 billion by 2030.

What is the Angiotensin Receptor Blockers (ARBs) market growth?

The global Angiotensin Receptor Blockers (ARBs) market is expected to grow at a CAGR of 4.7% from 2026 to 2035 to reach $11.02 billion by 2035.

Who are the key players in Angiotensin Receptor Blockers (ARBs) market?

Some Key Players in the Angiotensin Receptor Blockers (ARBs) market Include, Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company L

Major trend in this market includes: Innovative Product Solution In The Angiotensin Receptor Blockers Market. For further insights on this market. request a sample here

North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2025. The regions covered in the angiotensin receptor blockers (arbs) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe,

Book your 30 minutes free consultation with our research experts

Contact Us